These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9728331

  • 1. Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).
    Holme E, Lindstedt S.
    J Inherit Metab Dis; 1998 Aug; 21(5):507-17. PubMed ID: 9728331
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NTBC and alkaptonuria.
    Anikster Y, Nyhan WL, Gahl WA.
    Am J Hum Genet; 1998 Sep; 63(3):920-1. PubMed ID: 9718357
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).
    Pronicka E, Rowinska E, Bentkowski Z, Zawadzki J, Holme E, Lindstedt S.
    J Inherit Metab Dis; 1996 Sep; 19(2):234-8. PubMed ID: 8739974
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NTBC as palliative treatment in chronic tyrosinaemia type I.
    Ros J, Vilaseca MA, Lambruschini N, Mas A, Lindstedt S, Holme E.
    J Inherit Metab Dis; 1999 Jun; 22(5):665-6. PubMed ID: 10399099
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
    Barkaoui E, Debray D, Habès D, Ogier H, Bernard O.
    Arch Pediatr; 1999 May; 6(5):540-4. PubMed ID: 10370811
    [Abstract] [Full Text] [Related]

  • 11. New treatment for tyrosinaemia.
    Lancet; 1992 Oct 03; 340(8823):822-3. PubMed ID: 1357248
    [No Abstract] [Full Text] [Related]

  • 12. Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.
    Gibbs TC, Payan J, Brett EM, Lindstedt S, Holme E, Clayton PT.
    J Neurol Neurosurg Psychiatry; 1993 Oct 03; 56(10):1129-32. PubMed ID: 8410015
    [Abstract] [Full Text] [Related]

  • 13. Ophthalmic follow-up of patients with tyrosinaemia type I on NTBC.
    Gissen P, Preece MA, Willshaw HA, McKiernan PJ.
    J Inherit Metab Dis; 2003 Oct 03; 26(1):13-6. PubMed ID: 12872835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.
    Mayorandan S, Meyer U, Gokcay G, Segarra NG, de Baulny HO, van Spronsen F, Zeman J, de Laet C, Spiekerkoetter U, Thimm E, Maiorana A, Dionisi-Vici C, Moeslinger D, Brunner-Krainz M, Lotz-Havla AS, Cocho de Juan JA, Couce Pico ML, Santer R, Scholl-Bürgi S, Mandel H, Bliksrud YT, Freisinger P, Aldamiz-Echevarria LJ, Hochuli M, Gautschi M, Endig J, Jordan J, McKiernan P, Ernst S, Morlot S, Vogel A, Sander J, Das AM.
    Orphanet J Rare Dis; 2014 Aug 01; 9():107. PubMed ID: 25081276
    [Abstract] [Full Text] [Related]

  • 17. [Evolution of a case of tyrosinemia type I treated with NTBC].
    Ros Viladoms J, Vilaseca Buscà MA, Lambruschini Ferri N, Mas Comas A, González Pascual E, Holme E.
    An Esp Pediatr; 2001 Mar 01; 54(3):305-9. PubMed ID: 11262262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NTBC treatment in tyrosinaemia type I: long-term outcome in French patients.
    Masurel-Paulet A, Poggi-Bach J, Rolland MO, Bernard O, Guffon N, Dobbelaere D, Sarles J, de Baulny HO, Touati G.
    J Inherit Metab Dis; 2008 Feb 01; 31(1):81-7. PubMed ID: 18214711
    [Abstract] [Full Text] [Related]

  • 20. Corneal opacities associated with NTBC treatment.
    Ahmad S, Teckman JH, Lueder GT.
    Am J Ophthalmol; 2002 Aug 01; 134(2):266-8. PubMed ID: 12140036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.